Individually distinct tumor-specific cell surface antigen identified by monoclonal antibody on a Rous sarcoma virus-induced mouse tumor. 1982

N Kuzumaki, and H Minakawa, and T Miyazaki, and S Haraguchi, and T Matsuo, and T O Yoshida

Hybrid cell lines were prepared by the fusion of BALB/c myeloma P3U-1 cells with the lymphocytes of BALB/c mice that were immunized with syngeneic Rous sarcoma virus (RSV)-induced tumor CSA1M cells. Three clones of the hybrid progeny (3.4B2, 3.4C6, and 3.5C11) produced cytotoxic IgM antibodies against CSA1M cells. One of the clones, 3.5C11, was chosen for analysis of the detailed specificity. Both direct cytotoxicity assays and absorption tests revealed that monoclonal antibody from 3.5C11 was positive only with CSA1M cells and that it failed to react with other tumors, including 20 RSV-induced mouse tumors, and normal cells. The 3.5C11 monoclonal antibody alone, with or without exogenous complement, was suppressive in the therapy of ip injected CSA1M tumor in syngeneic hosts, and significant prolongation in survival was seen in the treated mice. These results clearly showed presence of an individually distinct tumor-specific cell surface antigen on an RSV-induced mouse tumor.

UI MeSH Term Description Entries
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D011916 Rats, Inbred F344 An inbred strain of rat that is used for general BIOMEDICAL RESEARCH purposes. Fischer Rats,Rats, Inbred CDF,Rats, Inbred Fischer 344,Rats, F344,Rats, Inbred Fisher 344,CDF Rat, Inbred,CDF Rats, Inbred,F344 Rat,F344 Rat, Inbred,F344 Rats,F344 Rats, Inbred,Inbred CDF Rat,Inbred CDF Rats,Inbred F344 Rat,Inbred F344 Rats,Rat, F344,Rat, Inbred CDF,Rat, Inbred F344,Rats, Fischer
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006825 Hybridomas Cells artificially created by fusion of activated lymphocytes with neoplastic cells. The resulting hybrid cells are cloned and produce pure MONOCLONAL ANTIBODIES or T-cell products, identical to those produced by the immunologically competent parent cell. Hybridoma
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

N Kuzumaki, and H Minakawa, and T Miyazaki, and S Haraguchi, and T Matsuo, and T O Yoshida
December 1977, Comptes rendus hebdomadaires des seances de l'Academie des sciences. Serie D: Sciences naturelles,
N Kuzumaki, and H Minakawa, and T Miyazaki, and S Haraguchi, and T Matsuo, and T O Yoshida
January 1976, Journal of the National Cancer Institute,
N Kuzumaki, and H Minakawa, and T Miyazaki, and S Haraguchi, and T Matsuo, and T O Yoshida
May 1981, Blood,
N Kuzumaki, and H Minakawa, and T Miyazaki, and S Haraguchi, and T Matsuo, and T O Yoshida
June 1987, Proceedings of the National Academy of Sciences of the United States of America,
N Kuzumaki, and H Minakawa, and T Miyazaki, and S Haraguchi, and T Matsuo, and T O Yoshida
June 1981, International journal of cancer,
N Kuzumaki, and H Minakawa, and T Miyazaki, and S Haraguchi, and T Matsuo, and T O Yoshida
November 1974, International journal of cancer,
N Kuzumaki, and H Minakawa, and T Miyazaki, and S Haraguchi, and T Matsuo, and T O Yoshida
September 1985, British journal of haematology,
N Kuzumaki, and H Minakawa, and T Miyazaki, and S Haraguchi, and T Matsuo, and T O Yoshida
April 1970, The Japanese journal of experimental medicine,
N Kuzumaki, and H Minakawa, and T Miyazaki, and S Haraguchi, and T Matsuo, and T O Yoshida
June 1986, Journal of embryology and experimental morphology,
N Kuzumaki, and H Minakawa, and T Miyazaki, and S Haraguchi, and T Matsuo, and T O Yoshida
July 1984, The Journal of clinical investigation,
Copied contents to your clipboard!